(1->4)-beta-D-glucan multiple interactions ISO RGD:736772 6480464 [perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of DDAH1 mRNA CTD PMID:36331819 1-nitropropane decreases expression EXP 6480464 1-nitropropane results in decreased expression of DDAH1 mRNA CTD PMID:17070881 17alpha-ethynylestradiol increases expression EXP 6480464 Ethinyl Estradiol results in increased expression of DDAH1 mRNA CTD PMID:17557909 17beta-estradiol affects expression ISO RGD:1343347 6480464 Estradiol affects the expression of DDAH1 mRNA CTD PMID:22574217 17beta-estradiol multiple interactions ISO RGD:1343347 6480464 [Estradiol co-treated with Progesterone] results in increased expression of DDAH1 mRNA, [Estradiol co-treated with TGFB1 protein] results in decreased expression of DDAH1 mRNA CTD PMID:20660070 , PMID:30165855 17beta-estradiol increases expression ISO RGD:736772 6480464 Estradiol results in increased expression of DDAH1 mRNA CTD PMID:19484750 2,3,4,7,8-Pentachlorodibenzofuran decreases expression EXP 6480464 2 more ... CTD PMID:21724226 2,3,7,8-tetrachlorodibenzodioxine affects expression EXP 6480464 Tetrachlorodibenzodioxin affects the expression of DDAH1 mRNA CTD PMID:22298810 , PMID:34747641 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:736772 6480464 Tetrachlorodibenzodioxin affects the expression of DDAH1 mRNA CTD PMID:21570461 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO RGD:1343347 6480464 Tetrachlorodibenzodioxin results in decreased expression of DDAH1 mRNA CTD PMID:20106945 , PMID:21632981 2,3,7,8-tetrachlorodibenzodioxine decreases expression EXP 6480464 Tetrachlorodibenzodioxin results in decreased expression of DDAH1 mRNA CTD PMID:21215274 , PMID:32109520 2,4-diaminotoluene increases expression EXP 6480464 2, 4-diaminotoluene results in increased expression of DDAH1 mRNA CTD PMID:17070881 2,4-dinitrotoluene affects expression EXP 6480464 2, 4-dinitrotoluene affects the expression of DDAH1 mRNA CTD PMID:21346803 2,6-diaminotoluene increases expression EXP 6480464 2, 6-diaminotoluene results in increased expression of DDAH1 mRNA CTD PMID:17070881 2,6-dinitrotoluene affects expression EXP 6480464 2, 6-dinitrotoluene affects the expression of DDAH1 mRNA CTD PMID:21346803 2-acetamidofluorene increases expression EXP 6480464 2-Acetylaminofluorene results in increased expression of DDAH1 mRNA CTD PMID:17070881 2-nitro-p-phenylenediamine increases expression EXP 6480464 2-nitro-4-phenylenediamine results in increased expression of DDAH1 mRNA CTD PMID:17070881 2-nitrofluorene increases expression EXP 6480464 2-nitrofluorene results in increased expression of DDAH1 mRNA CTD PMID:15890375 2-nitropropane increases expression EXP 6480464 2-nitropropane results in increased expression of DDAH1 mRNA CTD PMID:17070881 3,4-methylenedioxymethamphetamine affects expression EXP 6480464 N-Methyl-3, 4-methylenedioxyamphetamine affects the expression of DDAH1 mRNA CTD PMID:30071829 3-chloropropane-1,2-diol increases expression EXP 6480464 alpha-Chlorohydrin results in increased expression of DDAH1 mRNA CTD PMID:28522335 3H-1,2-dithiole-3-thione increases expression EXP 6480464 1, 2-dithiol-3-thione results in increased expression of DDAH1 mRNA CTD PMID:19162173 4,4'-sulfonyldiphenol increases expression ISO RGD:1343347 6480464 bis(4-hydroxyphenyl)sulfone results in increased expression of DDAH1 protein CTD PMID:34186270 4,4'-sulfonyldiphenol multiple interactions EXP 6480464 [bisphenol A co-treated with bisphenol F co-treated with bis(4-hydroxyphenyl)sulfone] results in increased expression of DDAH1 mRNA CTD PMID:36041667 4-(N-nitrosomethylamino)-1-(3-pyridyl)butan-1-one increases expression EXP 6480464 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in increased expression of DDAH1 mRNA CTD PMID:15890375 4-acetylaminofluorene decreases expression EXP 6480464 4-acetylaminofluorene results in decreased expression of DDAH1 mRNA CTD PMID:17070881 4-amino-2,6-dinitrotoluene affects expression EXP 6480464 4-amino-2, 6-dinitrotoluene affects the expression of DDAH1 mRNA CTD PMID:21346803 4-hydroxyphenyl retinamide increases expression ISO RGD:736772 6480464 Fenretinide results in increased expression of DDAH1 mRNA CTD PMID:28973697 4-hydroxyphenyl retinamide decreases expression ISO RGD:736772 6480464 Fenretinide results in decreased expression of DDAH1 mRNA CTD PMID:28973697 4-nitro-1,2-phenylenediamine increases expression EXP 6480464 1, 2-diamino-4-nitrobenzene results in increased expression of DDAH1 mRNA CTD PMID:17070881 6-propyl-2-thiouracil increases expression EXP 6480464 Propylthiouracil results in increased expression of DDAH1 mRNA CTD PMID:24780913 acetamide decreases expression EXP 6480464 acetamide results in decreased expression of DDAH1 mRNA CTD PMID:31881176 acrylamide increases expression EXP 6480464 Acrylamide results in increased expression of DDAH1 mRNA CTD PMID:28959563 aflatoxin B1 increases expression EXP 6480464 Aflatoxin B1 results in increased expression of DDAH1 mRNA CTD PMID:15890375 aflatoxin B1 decreases methylation ISO RGD:1343347 6480464 Aflatoxin B1 results in decreased methylation of DDAH1 gene CTD PMID:27153756 aflatoxin B1 decreases expression ISO RGD:736772 6480464 Aflatoxin B1 results in decreased expression of DDAH1 mRNA CTD PMID:19770486 all-trans-retinoic acid decreases expression ISO RGD:1343347 6480464 Tretinoin results in decreased expression of DDAH1 mRNA CTD PMID:23724009 all-trans-retinoic acid increases expression ISO RGD:1343347 6480464 Tretinoin results in increased expression of DDAH1 mRNA CTD PMID:33167477 Allylamine increases expression EXP 6480464 Allylamine results in increased expression of DDAH1 mRNA CTD PMID:15910882 ammonium chloride affects expression EXP 6480464 Ammonium Chloride affects the expression of DDAH1 mRNA CTD PMID:16483693 aristolochic acid A decreases expression ISO RGD:1343347 6480464 aristolochic acid I results in decreased expression of DDAH1 mRNA CTD PMID:33212167 benzo[a]pyrene decreases expression ISO RGD:736772 6480464 Benzo(a)pyrene results in decreased expression of DDAH1 mRNA CTD PMID:19770486 more ... benzo[a]pyrene decreases methylation ISO RGD:1343347 6480464 Benzo(a)pyrene results in decreased methylation of DDAH1 exon CTD PMID:27901495 benzo[a]pyrene increases methylation ISO RGD:1343347 6480464 Benzo(a)pyrene results in increased methylation of DDAH1 3' UTR CTD PMID:27901495 benzo[a]pyrene affects methylation ISO RGD:1343347 6480464 Benzo(a)pyrene affects the methylation of DDAH1 5' UTR, Benzo(a)pyrene affects the methylation of DDAH1 promoter CTD PMID:27901495 benzo[a]pyrene multiple interactions ISO RGD:736772 6480464 [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of DDAH1 mRNA CTD PMID:27858113 benzo[a]pyrene increases expression ISO RGD:736772 6480464 Benzo(a)pyrene results in increased expression of DDAH1 mRNA CTD PMID:22610609 benzo[a]pyrene diol epoxide I decreases expression ISO RGD:1343347 6480464 7 more ... CTD PMID:20018196 benzo[b]fluoranthene affects expression ISO RGD:736772 6480464 benzo(b)fluoranthene affects the expression of DDAH1 mRNA CTD PMID:26377693 benzo[b]fluoranthene multiple interactions ISO RGD:736772 6480464 [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of DDAH1 mRNA CTD PMID:27858113 bisphenol A affects expression EXP 6480464 bisphenol A affects the expression of DDAH1 mRNA CTD PMID:25181051 bisphenol A increases expression EXP 6480464 bisphenol A results in increased expression of DDAH1 mRNA CTD PMID:35192832 bisphenol A multiple interactions EXP 6480464 [bisphenol A co-treated with bisphenol F co-treated with bis(4-hydroxyphenyl)sulfone] results in increased expression of DDAH1 mRNA CTD PMID:36041667 bisphenol A increases methylation ISO RGD:1343347 6480464 bisphenol A results in increased methylation of DDAH1 gene CTD PMID:31601247 bisphenol A decreases expression ISO RGD:736772 6480464 bisphenol A results in decreased expression of DDAH1 mRNA CTD PMID:33221593 bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of DDAH1 mRNA CTD PMID:34947998 bisphenol A decreases expression ISO RGD:1343347 6480464 bisphenol A results in decreased expression of DDAH1 mRNA CTD PMID:29275510 bisphenol A increases methylation EXP 6480464 bisphenol A results in increased methylation of DDAH1 gene CTD PMID:28505145 bisphenol F multiple interactions EXP 6480464 [bisphenol A co-treated with bisphenol F co-treated with bis(4-hydroxyphenyl)sulfone] results in increased expression of DDAH1 mRNA CTD PMID:36041667 butan-1-ol multiple interactions ISO RGD:1343347 6480464 [[Gasoline co-treated with 1-Butanol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in increased expression of DDAH1 mRNA CTD PMID:29432896 cadmium dichloride increases expression ISO RGD:1343347 6480464 Cadmium Chloride results in increased expression of DDAH1 protein CTD PMID:24527689 carbamazepine affects expression ISO RGD:1343347 6480464 Carbamazepine affects the expression of DDAH1 mRNA CTD PMID:25979313 carbon nanotube decreases expression ISO RGD:736772 6480464 Nanotubes more ... CTD PMID:25620056 carbon nanotube increases expression ISO RGD:736772 6480464 Nanotubes more ... CTD PMID:25554681 chromium trinitrate decreases expression ISO RGD:736772 6480464 chromium nitrate results in decreased expression of DDAH1 protein CTD PMID:22144121 chromium(6+) affects expression ISO RGD:736772 6480464 chromium hexavalent ion affects the expression of DDAH1 mRNA CTD PMID:28472532 chrysene multiple interactions ISO RGD:736772 6480464 [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of DDAH1 mRNA CTD PMID:27858113 cisplatin multiple interactions ISO RGD:1343347 6480464 [Cisplatin co-treated with jinfukang] results in decreased expression of DDAH1 mRNA CTD PMID:27392435 clofibrate increases expression EXP 6480464 Clofibrate results in increased expression of DDAH1 protein CTD PMID:16470657 cobalt dichloride decreases expression ISO RGD:1343347 6480464 cobaltous chloride results in decreased expression of DDAH1 mRNA CTD PMID:19320972 cobalt dichloride decreases expression EXP 6480464 cobaltous chloride results in decreased expression of DDAH1 mRNA CTD PMID:24386269 copper atom multiple interactions ISO RGD:736772 6480464 [ATP7A gene mutant form results in increased abundance of Copper] which results in increased expression of DDAH1 mRNA CTD PMID:15467011 copper(0) multiple interactions ISO RGD:736772 6480464 [ATP7A gene mutant form results in increased abundance of Copper] which results in increased expression of DDAH1 mRNA CTD PMID:15467011 copper(II) sulfate decreases expression ISO RGD:1343347 6480464 Copper Sulfate results in decreased expression of DDAH1 mRNA CTD PMID:19549813 Cuprizon decreases expression EXP 6480464 Cuprizone results in decreased expression of DDAH1 mRNA CTD PMID:27523638 cyclosporin A decreases expression ISO RGD:1343347 6480464 Cyclosporine results in decreased expression of DDAH1 mRNA CTD PMID:20106945 cyclosporin A decreases expression ISO RGD:736772 6480464 Cyclosporine results in decreased expression of DDAH1 mRNA CTD PMID:19770486 dexamethasone increases expression ISO RGD:1343347 6480464 Dexamethasone results in increased expression of DDAH1 mRNA CTD PMID:25047013 dibenz[a,h]anthracene increases expression ISO RGD:736772 6480464 1 more ... CTD PMID:26377693 dibutyl phthalate increases expression ISO RGD:736772 6480464 Dibutyl Phthalate results in increased expression of DDAH1 mRNA CTD PMID:21266533 diethylstilbestrol increases expression EXP 6480464 Diethylstilbestrol results in increased expression of DDAH1 mRNA CTD PMID:15890375 dioxygen multiple interactions ISO RGD:736772 6480464 [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of DDAH1 mRNA, [sulforaphane affects the susceptibility to Oxygen] which affects the expression of DDAH1 mRNA CTD PMID:30529165 diuron decreases expression EXP 6480464 Diuron results in decreased expression of DDAH1 mRNA CTD PMID:21551480 dorsomorphin multiple interactions ISO RGD:1343347 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 doxorubicin decreases expression ISO RGD:1343347 6480464 Doxorubicin results in decreased expression of DDAH1 mRNA CTD PMID:29803840 ethanol increases expression ISO RGD:736772 6480464 Ethanol results in increased expression of DDAH1 mRNA CTD PMID:30319688 flavonoids increases expression EXP 6480464 Flavonoids results in increased expression of DDAH1 mRNA CTD PMID:18035473 flutamide decreases expression EXP 6480464 Flutamide results in decreased expression of DDAH1 mRNA CTD PMID:24136188 folic acid multiple interactions ISO RGD:736772 6480464 Folic Acid inhibits the reaction [AGT protein results in increased expression of DDAH1 mRNA], Folic Acid inhibits the reaction [AGT protein results in increased expression of DDAH1 protein] CTD PMID:24386282 folic acid decreases expression ISO RGD:736772 6480464 Folic Acid results in decreased expression of DDAH1 mRNA CTD PMID:25629700 formaldehyde decreases expression ISO RGD:1343347 6480464 Formaldehyde results in decreased expression of DDAH1 mRNA, Formaldehyde results in decreased expression of DDAH1 protein CTD PMID:17938736 more ... furan increases expression EXP 6480464 furan results in increased expression of DDAH1 mRNA CTD PMID:26194646 hydroquinone decreases expression ISO RGD:1343347 6480464 hydroquinone results in decreased expression of DDAH1 mRNA CTD PMID:31256213 indometacin multiple interactions EXP 6480464 Irbesartan inhibits the reaction [Indomethacin results in decreased expression of DDAH1 mRNA], Ranitidine inhibits the reaction [Indomethacin results in decreased expression of DDAH1 mRNA] CTD PMID:29523851 indometacin decreases expression EXP 6480464 Indomethacin results in decreased expression of DDAH1 mRNA CTD PMID:29523851 inulin multiple interactions ISO RGD:736772 6480464 [perfluorooctane sulfonic acid co-treated with Inulin] results in increased expression of DDAH1 mRNA CTD PMID:36331819 irbesartan multiple interactions EXP 6480464 Irbesartan inhibits the reaction [Indomethacin results in decreased expression of DDAH1 mRNA] CTD PMID:29523851 ivermectin decreases expression ISO RGD:1343347 6480464 Ivermectin results in decreased expression of DDAH1 protein CTD PMID:32959892 lead diacetate increases expression ISO RGD:736772 6480464 lead acetate results in increased expression of DDAH1 mRNA CTD PMID:20680508 lead diacetate increases expression EXP 6480464 lead acetate results in increased expression of DDAH1 mRNA CTD PMID:11578147 lead(0) affects expression ISO RGD:1343347 6480464 Lead affects the expression of DDAH1 mRNA CTD PMID:28903495 lead(2+) affects expression ISO RGD:1343347 6480464 Lead affects the expression of DDAH1 mRNA CTD PMID:28903495 manganese atom multiple interactions ISO RGD:736772 6480464 Paroxetine inhibits the reaction [Manganese deficiency results in decreased expression of DDAH1 protein] CTD PMID:21312047 manganese atom decreases expression ISO RGD:736772 6480464 Manganese deficiency results in decreased expression of DDAH1 protein CTD PMID:21312047 manganese(0) decreases expression ISO RGD:736772 6480464 Manganese deficiency results in decreased expression of DDAH1 protein CTD PMID:21312047 manganese(0) multiple interactions ISO RGD:736772 6480464 Paroxetine inhibits the reaction [Manganese deficiency results in decreased expression of DDAH1 protein] CTD PMID:21312047 methamphetamine affects expression EXP 6480464 Methamphetamine affects the expression of DDAH1 protein CTD PMID:17904249 methapyrilene increases expression EXP 6480464 Methapyrilene results in increased expression of DDAH1 mRNA CTD PMID:15890375 methapyrilene decreases expression EXP 6480464 Methapyrilene results in decreased expression of DDAH1 mRNA CTD PMID:30467583 methylmercury chloride increases expression ISO RGD:1343347 6480464 methylmercuric chloride results in increased expression of DDAH1 mRNA CTD PMID:23179753 , PMID:28001369 N-nitrosodimethylamine increases expression EXP 6480464 Dimethylnitrosamine results in increased expression of DDAH1 mRNA CTD PMID:15890375 N-nitrosomorpholine increases expression EXP 6480464 N-nitrosomorpholine results in increased expression of DDAH1 protein CTD PMID:19716841 N1'-[2-[[5-[(dimethylamino)methyl]-2-furanyl]methylthio]ethyl]-N1-methyl-2-nitroethene-1,1-diamine multiple interactions EXP 6480464 Ranitidine inhibits the reaction [Indomethacin results in decreased expression of DDAH1 mRNA] CTD PMID:29523851 nitrobenzenes decreases expression EXP 6480464 Nitrobenzenes analog results in decreased expression of DDAH1 mRNA CTD PMID:19784758 p-toluidine increases expression EXP 6480464 4-toluidine results in increased expression of DDAH1 mRNA CTD PMID:27638505 paracetamol decreases expression EXP 6480464 Acetaminophen results in decreased expression of DDAH1 mRNA CTD PMID:19784758 , PMID:33387578 paracetamol affects expression ISO RGD:736772 6480464 Acetaminophen affects the expression of DDAH1 mRNA CTD PMID:17562736 paracetamol increases expression EXP 6480464 Acetaminophen results in increased expression of DDAH1 mRNA CTD PMID:19784758 paracetamol affects expression EXP 6480464 Acetaminophen affects the expression of DDAH1 mRNA CTD PMID:19784758 paraquat increases expression EXP 6480464 Paraquat results in increased expression of DDAH1 mRNA CTD PMID:20388547 paroxetine multiple interactions ISO RGD:736772 6480464 Paroxetine inhibits the reaction [Manganese deficiency results in decreased expression of DDAH1 protein] CTD PMID:21312047 perfluorododecanoic acid increases expression EXP 6480464 perfluorododecanoic acid results in increased expression of DDAH1 protein CTD PMID:26168851 perfluorooctane-1-sulfonic acid decreases expression EXP 6480464 perfluorooctane sulfonic acid results in decreased expression of DDAH1 mRNA CTD PMID:19162173 perfluorooctane-1-sulfonic acid multiple interactions ISO RGD:736772 6480464 [perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of DDAH1 mRNA more ... CTD PMID:36331819 phenobarbital decreases expression EXP 6480464 Phenobarbital results in decreased expression of DDAH1 mRNA CTD PMID:19162173 phenobarbital decreases expression ISO RGD:736772 6480464 Phenobarbital results in decreased expression of DDAH1 mRNA CTD PMID:19270015 more ... phenylmercury acetate increases expression ISO RGD:1343347 6480464 Phenylmercuric Acetate results in increased expression of DDAH1 mRNA CTD PMID:26272509 phenylmercury acetate multiple interactions ISO RGD:1343347 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of DDAH1 mRNA CTD PMID:27188386 pioglitazone multiple interactions ISO RGD:736772 6480464 [N-nitroso-tris-chloroethylurea co-treated with pioglitazone] results in decreased expression of DDAH1 mRNA CTD PMID:27935865 piperonyl butoxide increases expression EXP 6480464 Piperonyl Butoxide results in increased expression of DDAH1 mRNA CTD PMID:15890375 pirinixic acid increases expression EXP 6480464 pirinixic acid results in increased expression of DDAH1 mRNA CTD PMID:15890375 , PMID:19162173 pirinixic acid increases expression ISO RGD:736772 6480464 pirinixic acid results in increased expression of DDAH1 mRNA CTD PMID:18301758 , PMID:23811191 potassium chromate decreases expression ISO RGD:736772 6480464 potassium chromate(VI) results in decreased expression of DDAH1 protein CTD PMID:22144121 pregnenolone 16alpha-carbonitrile decreases expression ISO RGD:736772 6480464 Pregnenolone Carbonitrile results in decreased expression of DDAH1 mRNA CTD PMID:28903501 progesterone multiple interactions ISO RGD:1343347 6480464 [Estradiol co-treated with Progesterone] results in increased expression of DDAH1 mRNA CTD PMID:20660070 propiconazole decreases expression ISO RGD:736772 6480464 propiconazole results in decreased expression of DDAH1 mRNA CTD PMID:21278054 ranitidine multiple interactions EXP 6480464 Ranitidine inhibits the reaction [Indomethacin results in decreased expression of DDAH1 mRNA] CTD PMID:29523851 rotenone affects expression EXP 6480464 Rotenone affects the expression of DDAH1 mRNA CTD PMID:28374803 sarin affects expression EXP 6480464 Sarin affects the expression of DDAH1 protein CTD PMID:28973502 SB 431542 multiple interactions ISO RGD:1343347 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 simvastatin decreases expression EXP 6480464 Simvastatin results in decreased expression of DDAH1 mRNA CTD PMID:16414398 sodium arsenite increases expression ISO RGD:1343347 6480464 sodium arsenite results in increased expression of DDAH1 mRNA CTD PMID:17879257 sodium arsenite increases expression ISO RGD:736772 6480464 sodium arsenite results in increased expression of DDAH1 protein CTD PMID:29044176 sodium arsenite decreases expression ISO RGD:1343347 6480464 sodium arsenite results in decreased expression of DDAH1 mRNA CTD PMID:29301061 sodium arsenite increases expression EXP 6480464 sodium arsenite results in increased expression of DDAH1 protein CTD PMID:29459688 sodium arsenite affects methylation ISO RGD:1343347 6480464 sodium arsenite affects the methylation of DDAH1 gene CTD PMID:28589171 sulforaphane multiple interactions ISO RGD:736772 6480464 [sulforaphane affects the susceptibility to Oxygen] which affects the expression of DDAH1 mRNA CTD PMID:30529165 taurine decreases expression ISO RGD:1343347 6480464 Taurine results in decreased expression of DDAH1 mRNA CTD PMID:16579726 temozolomide increases expression ISO RGD:1343347 6480464 Temozolomide results in increased expression of DDAH1 mRNA CTD PMID:31758290 Tesaglitazar increases expression EXP 6480464 tesaglitazar results in increased expression of DDAH1 mRNA CTD PMID:21515302 tetrachloromethane increases expression ISO RGD:736772 6480464 Carbon Tetrachloride results in increased expression of DDAH1 mRNA CTD PMID:17484886 tetrachloromethane decreases expression ISO RGD:736772 6480464 Carbon Tetrachloride results in decreased expression of DDAH1 mRNA CTD PMID:27339419 , PMID:31919559 tetrachloromethane decreases expression EXP 6480464 Carbon Tetrachloride results in decreased expression of DDAH1 mRNA CTD PMID:19784758 tetraphene multiple interactions ISO RGD:736772 6480464 [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of DDAH1 mRNA CTD PMID:27858113 thapsigargin decreases expression ISO RGD:1343347 6480464 Thapsigargin results in decreased expression of DDAH1 mRNA CTD PMID:22378314 thioacetamide decreases expression EXP 6480464 Thioacetamide results in decreased expression of DDAH1 mRNA CTD PMID:19784758 , PMID:34492290 thioacetamide increases expression EXP 6480464 Thioacetamide results in increased expression of DDAH1 mRNA CTD PMID:23411599 titanium dioxide increases expression ISO RGD:736772 6480464 titanium dioxide results in increased expression of DDAH1 mRNA CTD PMID:23557971 , PMID:27760801 trichloroethene decreases expression EXP 6480464 Trichloroethylene results in decreased expression of DDAH1 mRNA CTD PMID:33387578 trichostatin A decreases expression ISO RGD:1343347 6480464 trichostatin A results in decreased expression of DDAH1 mRNA CTD PMID:26272509 trichostatin A multiple interactions ISO RGD:1343347 6480464 [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of DDAH1 mRNA CTD PMID:27188386 triclosan decreases expression ISO RGD:1343347 6480464 Triclosan results in decreased expression of DDAH1 mRNA CTD PMID:30510588 triphenyl phosphate increases expression EXP 6480464 triphenyl phosphate results in increased expression of DDAH1 mRNA CTD PMID:30589522 valproic acid affects expression ISO RGD:736772 6480464 Valproic Acid affects the expression of DDAH1 mRNA CTD PMID:17292431 valproic acid increases expression ISO RGD:1343347 6480464 Valproic Acid results in increased expression of DDAH1 mRNA CTD PMID:23179753 more ... valproic acid affects expression ISO RGD:1343347 6480464 Valproic Acid affects the expression of DDAH1 mRNA CTD PMID:25979313 venlafaxine hydrochloride increases expression EXP 6480464 Venlafaxine Hydrochloride results in increased expression of DDAH1 mRNA CTD PMID:25423262 zoledronic acid decreases expression ISO RGD:1343347 6480464 zoledronic acid results in decreased expression of DDAH1 mRNA CTD PMID:24714768